上海联影医疗科技股份有限公司 2025年度业绩快报公告

Financial Performance - The company achieved total revenue of 1,382,064.02 million RMB in 2025, representing a year-on-year growth of 34.18% [1] - The net profit attributable to the parent company was 188,779.84 million RMB, an increase of 49.60% compared to the previous year [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 178,834.08 million RMB, reflecting a growth of 77.01% [1] Assets and Equity - By the end of 2025, the company's total assets reached 3,280,039.60 million RMB, marking a year-on-year increase of 17.00% [2] - The equity attributable to the parent company was 2,159,024.54 million RMB, which is an 8.48% increase from the previous year [2] Factors Influencing Performance - The company focused on building long-term competitiveness through the introduction of innovative products, deepening global market layout, optimizing supply chain systems, and accumulating core technological capabilities [3] - The demand for high-end medical imaging, radiotherapy, and grassroots diagnostic equipment in the Chinese market has significantly increased due to the normalization of large-scale medical equipment updates [3] - The company has maintained a leading position in the domestic market, with significant revenue growth and improved operational quality and profitability [3] - Internationally, the company has strengthened its global market expansion and innovation product introduction, achieving rapid growth in key regions such as Europe, North America, and Asia-Pacific [3] - The company is expected to enter a new phase of growth driven by technological innovation, improved efficiency through intelligent management, and enhanced global collaboration [3] Significant Changes in Financial Metrics - The company experienced over 30% changes in several financial metrics, including total revenue, operating profit, and net profit attributable to the parent company, primarily due to the continuous launch of innovative products and the increasing market recognition of high-end products [4] - Other contributing factors include the rapid growth of overseas business, optimization of management operations, and the gradual implementation of domestic equipment update policies [4]